ArticleAsian Pacific journal of cancer prevention : APJCP2025
Biosynthesis of Copper Nanoparticles Using Passiflora Flower Extract and Study Their Antimicrobial, Antioxidant And Anticancer Activity.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anti-inflammatory role of metal and metal oxide nanoparticles: a review of toxicity, green synthesis, and immunomodulatory mechanisms.Inflammopharmacology · 2026Review
- Polyherbal-Mediated Synthesis of Copper Nanoparticles UsingJournal of functional biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCopper nanoparticles (CuNPs) have received interest due to their antibacterial, antioxidant, and anticancer effects. However, current synthesis methods frequently use harmful substances. Green synthesis with plant extracts provides a safer, more environmentally friendly option. This study looks at the production of CuNPs with Passiflora flower extract and assesses their biological activity.
methodsPassiflora extract was used as a reducing and stabilizing agent in the synthesis of CuNPs. UV-Vis spectroscopy, FTIR, SEM, XRD, and AFM were used to characterize the samples. The biological activities were evaluated using DPPH antioxidant assays, antimicrobial tests against bacterial and fungal strains, and MTT assays on MCF7 cancer cells and HFF normal cells.
resultsThe CuNPs produced had a spherical form with an average size of 10-20 nm. Antioxidant activity was high, with an IC50 of 98.94 µg/ml. CuNPs showed broad-spectrum antibacterial activity, especially against Staphylococcus aureus and Candida albicans. The cytotoxicity assay revealed preferential toxicity against MCF7 breast cancer cells (IC50 = 47.01 µg/ml) while preserving normal HFF cells (IC50 = 128.35 µg/ml). These findings are consistent with prior research, confirming the potential biomedical applications of CuNPs.
conclusionGreen-synthesized CuNPs have substantial antioxidant, antibacterial, and anticancer properties. Their specific toxicity to cancer cells demonstrates their potential as a Nano medicine option. Further research into in vivo efficacy and long-term safety is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.